A new study published in Translational Psychiatry, concluded CBD could represent “a completely new mechanism in the treatment of schizophrenia.” The Phase II study was randomized, controlled, and double-blind. Forty two “acutely exacerbated schizophrenic patients” were randomly assigned to a three-week treatment of CBD or a standard antipsychotic medication (amisulpride). In progressive steps, the patients received up to […]

The psychiatric research journal JAMA Psychiatry has just published a new study suggesting CBD could have antipsychotic effects in individuals at clinical high risk of psychosis. For this study, researchers wanted to try to isolate the specific chemical alterations that give CBD its therapeutic and potentially antipsychotic effects. The investigation revealed that all three brain […]